16th Biosimilar Conference
|This year’s flagship event will gather top EU and global regulators, officials, healthcare actors as well as industry leaders, to foster open exchange and debate on the role of the biosimilar medicines sector in “Biosimilar Medicines: Unlocking the Full Potential of Biologics”.
Over two days, participants will dive into a dynamic programme – a crossroads between technical, scientific, market discussions and the overarching healthcare policy agenda.
- HDAP Meeting / Conference Call
- Sep 24 2018
- All of the day
Wind: 11 KPH
Humidity: 1 %
Visibility: 10 KM